Summary & Overview
HCPCS Level II J9000: Doxorubicin Hydrochloride Injection, 10 mg
Headline: HCPCS Level II code J9000 denotes doxorubicin hydrochloride injections used in systemic chemotherapy. Lead: HCPCS Level II code J9000 identifies a 10 mg unit of doxorubicin hydrochloride (Adriamycin), an established cytotoxic agent used across multiple malignancies in infusion-based oncology care. Why it matters: Accurate use of J9000 is critical for clinical documentation, drug inventory control, and payer adjudication for chemotherapy services provided in outpatient infusion settings nationwide. Key payers covered: Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. What readers will learn: This briefing explains the clinical and billing context for J9000, outlines common billing considerations tied to chemotherapy drug administration, and distinguishes this formulation from related lipid formulations billed under separate codes. It summarizes payer coverage landscape and common claim-line elements relevant to infusion services. Clinical context: Doxorubicin is a foundational anthracycline chemotherapy used for a range of solid tumors and hematologic malignancies; J9000 captures the drug product delivered per 10 mg unit. Administrative context: The code applies to drug reporting on the claim line for infusion visits typically performed in outpatient infusion centers. Data limitations: Service-line metadata is missing from the input; specifics about local coverage determinations or state-level policy are not provided. Readers should expect concise benchmarks for claim reporting practices, common clinical indications linked to use of the drug, and a summary of payer presence without state-specific coverage directives.
Billing Code Overview
HCPCS Level II code J9000 represents an injection of doxorubicin hydrochloride (Adriamycin), 10 mg. This code is used to report the chemotherapy drug itself when administered as part of an oncology treatment regimen.
Service Type: Chemotherapy drug administration
Typical Site of Service: Infusion setting (for example, outpatient infusion center)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a confirmed diagnosis of metastatic breast cancer presents to an outpatient infusion center for systemic chemotherapy. The treatment plan orders doxorubicin hydrochloride for administration via intravenous infusion as part of a multi-agent regimen. The clinical workflow includes verification of the oncologist’s chemotherapy order, review of recent labs (complete blood count, hepatic and renal function), venous access assessment (peripheral IV or central line), premedication as indicated, preparation of the drug by pharmacy in an appropriate sterile environment, administration in the infusion chair by an oncology nurse, observation for infusion-related reactions, documentation of administered dose and lot number, and billing for the drug using HCPCS Level II code J9000 per 10 mg unit.
Coding Specifications
-
Modifiers:
-
JW- Drug amount discarded/not administered to any patient. Use when a portion of the dispensed vial is discarded and the discarded amount must be reported separately from the administered amount. -
59- Distinct Procedural Service. Use when a service or procedure that is not normally reported together is distinct because it was performed at a separate session or was a separate encounter. -
Provider Taxonomies:
-
207RH0003X- Hematology & Oncology Physician